Distinct molecular subtypes of uterine leiomyosarcoma respond differently to chemotherapy treatment
Open Access
- 11 September 2017
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 17 (1) , 639
Abstract
Uterine leiomyosarcoma (ULMS) is an aggressive form of soft tissue tumors. The molecular heterogeneity and pathogenesis of ULMS are not well understood. Expression profiling data were used to determine the possibility and optimal number of ULMS molecular subtypes. Next, clinicopathological characters and molecular pathways were analyzed in each subtype to prospect the clinical applications and progression mechanisms of ULMS. Two distinct molecular subtypes of ULMS were defined based on different gene expression signatures. Subtype I ULMS recapitulated low-grade ULMS, the gene expression pattern of which resembled normal smooth muscle cells, characterized by overexpression of smooth muscle function genes such as LMOD1, SLMAP, MYLK, MYH11. In contrast, subtype II ULMS recapitulated high-grade ULMS with higher tumor weight and invasion rate, and was characterized by overexpression of genes involved in the pathway of epithelial to mesenchymal transition and tumorigenesis, such as CDK6, MAPK13 and HOXA1. We identified two distinct molecular subtypes of ULMS responding differently to chemotherapy treatment. Our findings provide a better understanding of ULMS intrinsic molecular subtypes, and will potentially facilitate the development of subtype-specific diagnosis biomarkers and therapy strategies for these tumors.Keywords
Funding Information
- The National Natural Science Foundation of China (No. 81602362)
- the program for Science and Technology Development in Henan Province (No.162102310391)
- the program for Young Key Teacher of Henan Province (No.2016GGJS-214)
- the key program for Science and Technology Research of Henan Department of Education (No.15A310001)
- the supporting grants of Henan University (No.2015YBZR048, No.B2015151)
- the supporting grants of Henan University (No.2015YBZR046)
- Yellow River Scholar Program (No.H2016012)
- the program for Innovative Talents of Science and Technology in Henan Province (No. 18HASTIT048)
This publication has 38 references indexed in Scilit:
- Identification of Molecular Subtypes of Gastric Cancer With Different Responses to PI3-Kinase Inhibitors and 5-FluorouracilGastroenterology, 2013
- Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGFβ signaling in FTAADInternational Journal of Cardiology, 2013
- Leiomodin 1, a New Serum Response Factor-dependent Target Gene Expressed Preferentially in Differentiated Smooth Muscle CellsJournal of Biological Chemistry, 2012
- Gene set enrichment analysis: performance evaluation and usage guidelinesBriefings in Bioinformatics, 2011
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011Annals of Oncology, 2011
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item trackingBioinformatics, 2010
- Molecular Profiling of Endometrial MalignanciesObstetrics and Gynecology International, 2010
- Gene Expression Profiling Identifies Molecular Subtypes of Inflammatory Breast CancerCancer Research, 2005
- A novel isoform of sarcolemmal membrane-associated protein (SLMAP) is a component of the microtubule organizing centreJournal of Cell Science, 2004
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001